dabigatran etexilate 150 MG Oral Pellet [Pradaxa]

RxNorm concept 2590621, branded drug (sbd). Prescribable name: Pradaxa 150 MG Oral Pellet.

RxCUI: 2590621
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2590621 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

dabigatran etexilate 1037042

Other names

Pradaxa 150 MG Oral Pellet

Related concepts

dabigatran etexilate 150 MG (SCDC, consists of)
dabigatran etexilate 150 MG [Pradaxa] (SBDC, consists of)
Oral Pellet (DF, has dose form)
Pradaxa (BN, has ingredient)
dabigatran etexilate 150 MG Oral Pellet (SCD, tradename of)

Linked data

NDCs

00597045016

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2590621 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2590621 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2590621. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.